Literature DB >> 23908010

Treatment of chronic hepatitis C with protease inhibitor-based therapy after liver transplantation.

K Rajender Reddy1, Gregory T Everson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23908010     DOI: 10.1002/hep.26612

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  5 in total

Review 1.  Drug-drug interactions with oral anti-HCV agents and idiosyncratic hepatotoxicity in the liver transplant setting.

Authors:  Sarah Tischer; Robert J Fontana
Journal:  J Hepatol       Date:  2013-11-23       Impact factor: 25.083

Review 2.  Management of hepatitis C infection before and after liver transplantation.

Authors:  Stefano Fagiuoli; Roberto Ravasio; Maria Grazia Lucà; Anna Baldan; Silvia Pecere; Alessandro Vitale; Luisa Pasulo
Journal:  World J Gastroenterol       Date:  2015-04-21       Impact factor: 5.742

Review 3.  Management of Hepatitis C Before and After Liver Transplantation in the Era of Rapidly Evolving Therapeutic Advances.

Authors:  Chalermrat Bunchorntavakul; K Rajender Reddy
Journal:  J Clin Transl Hepatol       Date:  2014-06-15

4.  Tolerability and effectiveness of sofosbuvir and simeprevir in the post-transplant setting: systematic review and meta-analysis.

Authors:  Nghia H Nguyen; Brittany E Yee; Christine Chang; Minjuan Jin; Glen Lutchman; Joseph K Lim; Mindie H Nguyen
Journal:  BMJ Open Gastroenterol       Date:  2016-01-04

Review 5.  Should we consider patients with coexistent hepatitis B or C infection for orthotopic heart transplantation?

Authors:  Baskar Sekar; Pippa J Newton; Simon G Williams; Steven M Shaw
Journal:  J Transplant       Date:  2013-11-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.